The 2011-2014 prevalence of eosinophilic oesophagitis in the elderly amongst 10 million patients in the United States
- PMID: 25809664
- DOI: 10.1111/apt.13171
The 2011-2014 prevalence of eosinophilic oesophagitis in the elderly amongst 10 million patients in the United States
Abstract
Background: Eosinophilic oesophagitis (EoE) is primarily diagnosed by clinicians. There are less than a handful of epidemiological studies in EoE that have included elderly patients (>65 years).
Aim: To determine the prevalence of elderly subjects among EoE patients and compare their clinical presentation, associated conditions and treatment modalities with adult and paediatric EoE patients.
Methods: A large nationwide database (Explorys) between January 2011 and January 2014 was used. The term 'Eosinophilic Oesophagitis' was used in the Explorys search tool. The patient population was divided into three groups, Paediatric (<18 years), Adult (18-65 years) and Elderly (>65 years).
Results: We identified 4840 patients coded as EoE. The total estimated prevalence was 50.6 cases per 100 000 patients (0.05%). A total of 360 cases (7.44%) were elderly patients with an estimated prevalence rate of 18.6 cases per 100 000. Across all age groups, the majority of EoE patients were Caucasians and males. A significantly greater proportion of older patients had concomitant GERD. Dysphagia was the most common symptom among elderly EoE patients as compared with the paediatric EoE patients (P < 0.001). The proportion of elderly EoE patients with food allergies or asthma was significantly lower as compared with paediatric and adult EoE patients (P < 0.001). Oesophageal dilation and/or proton pump inhibitor treatment were the most commonly used therapeutic modalities in elderly EoE patients.
Conclusion: Eosinophilic oesophagitis is uncommon in elderly subjects and the clinical presentation is markedly different as compared with adults or the paediatric population.
© 2015 John Wiley & Sons Ltd.
Comment in
-
Letter: oesophageal eosinophilia must be excluded before determining prevalence of eosinophilic oesophagitis.Aliment Pharmacol Ther. 2015 Sep;42(5):628. doi: 10.1111/apt.13250. Aliment Pharmacol Ther. 2015. PMID: 26238579 No abstract available.
-
Letter: oesophageal eosinophilia must be excluded before determining prevalence of eosinophilic oesophagitis--authors' reply.Aliment Pharmacol Ther. 2015 Sep;42(5):629. doi: 10.1111/apt.13317. Aliment Pharmacol Ther. 2015. PMID: 26238580 No abstract available.
Similar articles
-
The 2010-2015 Prevalence of Eosinophilic Esophagitis in the USA: A Population-Based Study.Dig Dis Sci. 2016 Oct;61(10):2928-2934. doi: 10.1007/s10620-016-4204-4. Epub 2016 Jun 1. Dig Dis Sci. 2016. PMID: 27250980 Free PMC article.
-
Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings.Aliment Pharmacol Ther. 2014 Mar;39(6):603-8. doi: 10.1111/apt.12636. Epub 2014 Jan 26. Aliment Pharmacol Ther. 2014. PMID: 24461332
-
Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients.J Gastroenterol. 2017 Feb;52(2):203-210. doi: 10.1007/s00535-016-1213-1. Epub 2016 Apr 23. J Gastroenterol. 2017. PMID: 27108416
-
Therapeutic concepts in adult and paediatric eosinophilic oesophagitis.Nat Rev Gastroenterol Hepatol. 2012 Dec;9(12):697-704. doi: 10.1038/nrgastro.2012.182. Epub 2012 Sep 25. Nat Rev Gastroenterol Hepatol. 2012. PMID: 23007477 Review.
-
Diagnosis and treatment of eosinophilic esophagitis in clinical practice.Clin J Gastroenterol. 2017 Apr;10(2):87-102. doi: 10.1007/s12328-017-0725-4. Epub 2017 Feb 28. Clin J Gastroenterol. 2017. PMID: 28247277 Review.
Cited by
-
Brief Report: Elevated Red Cell Distribution Width Identifies Elevated Cardiovascular Disease Risk in Patients With HIV Infection.J Acquir Immune Defic Syndr. 2017 Mar 1;74(3):298-302. doi: 10.1097/QAI.0000000000001231. J Acquir Immune Defic Syndr. 2017. PMID: 27828877 Free PMC article.
-
The 2010-2015 Prevalence of Eosinophilic Esophagitis in the USA: A Population-Based Study.Dig Dis Sci. 2016 Oct;61(10):2928-2934. doi: 10.1007/s10620-016-4204-4. Epub 2016 Jun 1. Dig Dis Sci. 2016. PMID: 27250980 Free PMC article.
-
Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan.Drugs. 2024 Jun;84(6):661-684. doi: 10.1007/s40265-024-02037-0. Epub 2024 Jun 8. Drugs. 2024. PMID: 38849701 Free PMC article. Review.
-
Heart failure in patients with human immunodeficiency virus infection: Epidemiology and management disparities.Int J Cardiol. 2016 Sep 1;218:43-46. doi: 10.1016/j.ijcard.2016.05.027. Epub 2016 May 13. Int J Cardiol. 2016. PMID: 27232910 Free PMC article.
-
Eosinophilic esophagitis in individuals with sex chromosome aneuploidies: Clinical presentations and management implications.Mol Genet Genomic Med. 2021 Dec;9(12):e1833. doi: 10.1002/mgg3.1833. Epub 2021 Nov 5. Mol Genet Genomic Med. 2021. PMID: 34738344 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical